DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | A211479 | MSN LABORATORIES PRIVATE LTD
| Code | Date | Status |
|---|---|---|
| PC | Oct 3, 2026 | < 1 year |
Dapagliflozin and Metformin Hydrochloride (NDA 211479, Supplement 003) acquired pediatric exclusivity.
New: New record
MSN added pediatric exclusivity to dapagliflozin and metformin hydrochloride (NDA 211479, Supplement 004), extending regulatory exclusivity by six months.
New: New record
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (dapagliflozin; metformin hydrochloride) gained pediatric exclusivity for application A211479.
New: New record
MSN added pediatric exclusivity to dapagliflozin and metformin hydrochloride (NDA 211479, Supplement 002), extending regulatory exclusivity by six months.
New: New record